News

Blue reliever inhalers act quickly to treat symptoms and attacks, and people need to carry them for if their asthma flares up.However, a new warning from the regulator, the UK's Medicines and ...
Discover how African American families are navigating asthma care amid alarming health disparities, with actionable ...
Ariana Boyle, 7, has been hospitalised her more than 50 times due to her severe brittle asthma - but a last-resort treatment ...
Researchers have identified a compound that could block certain life-threatening and hard-to-treat allergic reactions.
Asthma is a chronic condition which leads to the airways to constrict and makes breathing difficult. Asthma has no cure, although medication can help manage symptoms. Asthma can be diagnosed and ...
Blue Cross is requiring at-home injection for severe asthma drugs in five states, raising concerns among doctors and patients ...
Last year, the FDA approved the biologic drug Dupixent to treat uncontrolled eosinophilic COPD. The approval marked a step ...
A new study from researchers at New York University and the University of Chicago offers a promising answer. The team, led by Dr. Jeffrey Hubbell and published in Science Translational Medicine, has ...
Health insurer Blue Cross Blue Shield just adopted a policy that will force many people with serious asthma and allergy ...
This reminder follows updates to product information and the National Institute for Health and Care Excellence (NICE) ...
Irritable bowel syndrome, chronic itching, asthma and migraine are in many cases hard-to-treat conditions. They have in common that they are triggered by an excessive immune response -- which in ...
New Phase II data demonstrate amlitelimab’s efficacy in heterogeneous inflammatory asthma, as lunsekimig and itepekimab ...